Cargando…

Recombinant human erythropoietin for treating severe traumatic brain injury

BACKGROUND: This study aimed to explore the efficacy and safety of recombinant human erythropoietin (RHE) for the treatment of severe traumatic brain injury (STBI). METHODS: One hundred and twenty eligible patients with STBI were randomly divided into an intervention group or a control group equally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Xiao-Fei, Gao, Yong-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943123/ https://www.ncbi.nlm.nih.gov/pubmed/29505528 http://dx.doi.org/10.1097/MD.0000000000009532

Ejemplares similares

The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury
por: Skrifvars, Markus B., et al.
Publicado: (2023)

Efficacy and safety of erythropoietin for traumatic brain injury
por: Liu, Motao, et al.
Publicado: (2020)

Preparation and Evaluation of Recombinant Human Erythropoietin Loaded Tween 80-Albumin Nanoparticle for Traumatic Brain Injury Treatment
por: Xue, Yuanfeng, et al.
Publicado: (2020)

Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury
por: Presneill, Jeffrey, et al.
Publicado: (2014)

Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury
por: Zhou, Zi‐wei, et al.
Publicado: (2017)

Effects of Quercetin and Mannitol on Erythropoietin Levels in Rats Following Acute Severe Traumatic Brain Injury
por: Kalemci, Orhan, et al.
Publicado: (2017)

Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury
por: Blixt, Jonas, et al.
Publicado: (2018)

Experimental studies of erythropoietin protection following traumatic brain injury in rats
por: XU, FENG, et al.
Publicado: (2012)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial
por: Nichol, Alistair, et al.
Publicado: (2015)

Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice
por: Klepper, Simon, et al.
Publicado: (2022)

Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way?
por: Grasso, Giovanni, et al.
Publicado: (2016)

The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
por: Kim, Moon Sun, et al.
Publicado: (2010)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists
por: Birkhoff, Willem A. J., et al.
Publicado: (2018)

Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial
por: Nirula, R., et al.
Publicado: (2010)

Endothelial Nitric Oxide Synthase Mediates the Cerebrovascular Effects of Erythropoietin in Traumatic Brain Injury
por: Cruz Navarro, Jovany, et al.
Publicado: (2014)

Research in the precaution of recombinant human erythropoietin to steroid-induced osteonecrosis of the rat femoral head
por: Jiang, Lu-yong, et al.
Publicado: (2017)

The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia
por: Robach, Paul, et al.
Publicado: (2008)

Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016)

Transcriptomic and bioinformatics analysis of the mechanism by which erythropoietin promotes recovery from traumatic brain injury in mice
por: Tan, Weilin, et al.
Publicado: (2023)

Ameliorative Effect of Recombinant Human Erythropoietin and Ischemic Preconditioning on Renal Ischemia Reperfusion Injury in Rats
por: Elshiekh, Mohammed, et al.
Publicado: (2015)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats
por: Robinson, Shenandoah, et al.
Publicado: (2018)

Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor
por: Hellewell, Sarah C, et al.
Publicado: (2013)

Preoperative recombinant human erythropoietin in anemic surgical patients
por: Monk, Terri G
Publicado: (2004)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Expression of adrenomedullin in rats after spinal cord injury and intervention effect of recombinant human erythropoietin
por: Zhao, Liang, et al.
Publicado: (2016)

Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome
por: Woo, Da Eun, et al.
Publicado: (2016)

Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
por: Greer, Joel W., et al.
Publicado: (1999)

Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013)

Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model
por: Anderson, Gail D., et al.
Publicado: (2013)

Recombinant human erythropoietin protects against immature brain damage induced by hypoxic/ischemia insult
por: Sun, Zhengda, et al.
Publicado: (2023)

Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin
por: Yang, Xiaowei, et al.
Publicado: (2021)

Therapeutic effect of erythropoietin on brain injury in premature mice with intrauterine infection
por: Liu, Hongxue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ouj2vnhnvfccgro3ch2odfpouu